Napredna pretraga

Pregled bibliografske jedinice broj: 119051

Gastric cancer: the role of insulin-like growth factor 2 (IGF 2) and its receptors (IGF IR and M6-P/IGF 2R)


Pavelić, Krešimir; Kolak, Toni; Kapitanović, Sanja; Radošević, Senka; Spaventi, Šime; Krušlin, Božo; Pavelić, Jasminka
Gastric cancer: the role of insulin-like growth factor 2 (IGF 2) and its receptors (IGF IR and M6-P/IGF 2R) // Journal of pathology, 201 (2003), 3; 430-438 (međunarodna recenzija, članak, znanstveni)


Naslov
Gastric cancer: the role of insulin-like growth factor 2 (IGF 2) and its receptors (IGF IR and M6-P/IGF 2R)

Autori
Pavelić, Krešimir ; Kolak, Toni ; Kapitanović, Sanja ; Radošević, Senka ; Spaventi, Šime ; Krušlin, Božo ; Pavelić, Jasminka

Izvornik
Journal of pathology (0022-3417) 201 (2003), 3; 430-438

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
Insulin-like growth factor 2; IGF 1 receptor; IGF 2 receptor; gastric cancer; autocrine loop; molecularly targeted therapy

Sažetak
Insulin-like growth factor 2 (IGF 2) appears to be involved in the progression of many tumors. It binds to at least two different types of receptor: IGF type 1 (IGF 1R) and mannose 6-phosphate/IGF type 2 (M6-P/IGF 2R). Ligand binding to IGF 1R provokes mitogenic and anti-apoptotic effects. M6-P/IGF 2R has a tumour suppressor function - it mediates IGF 2 degradation. Mutation of M6-P/1GF 2R causes both diminished growth suppression and augmented growth stimulation. The aim of this study was to investigate the role of IGF2 and its receptors (IGF 1R and IGF 2R) in human gastric cancer. The expression of IGF 2 and its receptors was measured in order to analyse the possible correlation between the activity of these genes and cell proliferation in two different gastric tumour types: diffuse and intestinal. The effect of IGF 1 receptor blockage on cell proliferation and anchorage-independent cell growth was also examined. Increased expression of IGF 2 and IGF 1R genes (at the mRNA and protein level) was found in gastric cancer when compared with nontumour tissue. Furthermore, there was a significant difference between IGF 2 expression in the more aggressive diffuse type and that in the intestinal type of gastric cancer. Moreover, the IGF 2 peptide level in the culture media obtained from the diffuse type of cancer cells was significantly higher when compared with the intestinal type. The level of IGF 2 peptide in the conditioned media strongly correlated with (3H)thymidine incorporation and cell proliferation. On the contrary, IGF 2R mRNA expression was much higher in the intestinal type of cancer than in the diffuse type. In addition, IGF 2R protein expression was substantially lower with progression of the diffuse cancer type to a higher stage. The alphaIR3 monoclonal antibody strongly inhibited (3H) thymidine incorporation and decreased the number of colonies in soft agar of cells overexpressing IGF 2. These findings suggest that members of the IGF family are involved in the pathogenesis of gastric cancer, probably by autocrine/paracrine stimulation of cell growth. Such tumours might be excellent candidates for therapeutic strategies aimed at interference with this pathway.

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti



POVEZANOST RADA


Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE